Krsnaa Diagnostics Limited IPO Message Board (Page 13)

Side-Effects of BULL MARKET

-People think Fundamental doesn’t matter

-People think They know everything

-People think They should leave job and become full time trader

-People don’t remember even their finance minister

-Each and every stocks look like multibagger

- Feel & Talk Like a Fund Manger

Very True and fine points, however, my experience of over 3 decades in Indian stock markets tells me that it is too early to think on those lines in current bull run. It is too young. Ride the wave....

Very well said 👌👌

If FY21 was not a Covid year, Krsnaa Diagnostics would''ve continued the Loss making run for another year, which is clearly a big negative fundamentally. Without any outside kick, it can''t run profitably like other Diagnostic companies i think 🤔🤔

PS: Shouldn''t think about all these petty things when in Bullish market and IPO Euphoria 😜😂

Krsnaa Diagnostics IPO – *Market’s Current Estimates of oversubscription*:

NII = 30KCrs. = ~167.60X
RII = 35L Forms = 41.97X Applic. wise (Avg allotment of ~0.36 shares per lot)

Interest cost *@10.00%p.a.* for 7days = *182.96paise for 1X*

Thus, for NII the costing = 167.60 X 182.96paise = Rs.306.63 per share (= GMP)

And, for RII the costing = 306.63 X 0.36 = Rs.110/- (= Kostak)


Krsnaa Diagnostics IPO – *GMP Estimated*

GMP 345 +/- 2
Kostak 125 +/- 25
Subject 2 @4,400/-

ok

Krsnna IPO
GMP 345 +/- 5

Thank you @eagleye madam

Please update daily

I have 45k funds for 3 lots on Devyani and Krsnaa.....which way is better lot wise
Devyani-1, Krsnaa-2
Krsnaa-2, Devyani-1
Thanks In Advance

Both are oversubscribed so no point of applying for 2 lots.

If separate demats go for devyani

345 350

Again seller circuit....

Everything will get clear and must apply for listing gain

Listing gain is there .

But hni cost ?

In glemark n rolex both r under hni cost so hni bare huge loss .

Gmp of Krsnaa diagnostics is 360 - 365 rs..
Apply for listing gain

Latest Gmp
Glenmark Life Rs 85
Rolex Rings Rs 450
Windlas Biotech Rs 130
Devyani Int. Rs 60      
Krsnaa Diagnostics Rs 450
Exxaro Tiles Rs 20      
CarTrade Rs 650

When will alott ipo

Rate of interest is 10%

Apply for listing might be 700+ or double if market goes well
Also want to point out eagle eye mam has considered interest cost at 10% while in previous all ipo at 8 percent

Vvv important question here is whether funds of Devyani and Krsnaa will be available for CarTrade or not?

In case of Aptus their closing date is 12th and all the current IPO will start refund process on 12th.
So it will be a very tough.
And if u really want to apply in Aptus and has fund shortage, my suggestion would be to not take risk.

@BubbleBoy- 99% chance is NO, unless basis of allotment Day is advanced. Both Devyani and Krsnaa have 11th Aug as Basis of Allotment Date(it will take minimum evening time for unblock of funds) and CarTrade last bidding date is 11th Aug only. However you can take chance via UPI mode which gives you the extra day to approve the mandate. Thanks

Only seller 330

Nbfc not giving funding for this .

Be cautious

anyone facing issue wiht icici bank asba, i am getting message that icici direct login, but i have zerotha account and have earlier apllied thru iciici netbanking asba and alotted as well. can anyone help.

My Priority on the basis of Listing gain and Chances of Allotment in IPO:

1️⃣ Devyani International
GMP: Rs 50-Rs 52 per share
Expected Listing Gain: Approx. Rs 8,000 per lot

2️⃣ Krsnaa Dianostics
GMP: Rs 370-Rs 375 Per share
Expected Listing Gain: Approx. Rs 5,500 per lot


3️⃣ Cartrade Tech
GMP :Rs 550 per share
Expected Listing Gain: Approx. Rs 4,800 per lot

I''m Not applying in Following IPOs:
Windlas Biotech
Exxaro Tiles
Nuvoco Vistas Corporation
Chemplast Sanmar

How may application we can do with IDFC First Bank any body have idea?

Ahmedabadone, it will be useful if you put SEBI notification here. Lot of people will stop asking the question, if they read the notification. Otherwise God will help them.
Help the people.

Krsnaa Diagnostics - For those who care beyond the GMP (based on FY21 consolidated financials & post-money (top end of the price band)):

RoCE (%): 74.5%
RoE (%): -1.8%

EV / Revenue (X): 6.7x
EV / EBITDA (X): 28.5x

The above is based on EBITDA & PAT adjusted for the Gain / Loss due to change in FV of CCPS with tax at effective corporate income tax rate for FY21.